--Advertisement--
Advertisement

COVID-19: Nigeria records 655 fresh infections — but more recoveries

covid 19 Omicron covid 19 Omicron

The Nigeria Centre for Disease Control (NCDC) says the country recorded 655 new COVID-19 cases across 20 states and the federal capital territory (FCT) on Wednesday.

The agency also said Nigeria recorded 875 recoveries in 24 hours, bringing the total number of persons discharged to 130,818.

Although still on the low side, the new positive cases are the highest daily count of fresh infections this week. 521 fresh infections were reported on Sunday, 542 on Monday, and 571 confirmed on Tuesday.

The single-day count recorded on Wednesday represents 14.71 percent increase compared to the previous day.

Advertisement

A total of 5,342 COVID-19 cases have been confirmed within a week (from February 17 to date).

Lagos, the hardest-hit state by the COVID-19 pandemic in Nigeria, recorded the highest number of new positive samples with 240 cases — representing 36.64 percent of the total infections reported on Wednesday.

Ogun follows Lagos with 88 fresh COVID-19 cases, while Rivers and the FCT recorded 56 and 51 positive samples respectively.

Advertisement

Other states that recorded new cases are Kaduna (43), Kano (25), Plateau (21), Taraba (19), Edo (17), Abia (15), Delta (13), Nasarawa (11), Akwa Ibom (10), Kwara (10), Oyo (10), Kebbi (9), Borno (5), Bayelsa (4), Gombe (4), Ekiti (2), and Osun (2)

However,  the NCDC said Wednesday’s data from Edo state is a total of all coronavirus cases reported over the last two days.

“297 community recoveries in Lagos and 93 community recoveries in Edo managed in line with guidelines,” it said.

Despite the rise in total discharged patients, Nigeria confirmed 11 deaths on Wednesday, with this, the COVID-19 casualty toll in the country now stands at 1,885.

Advertisement

A total of 153,842 cases have now been confirmed across the 36 states of the federation and the FCT, but there are currently 21,116 active cases.

Advertisement
Add a comment

Leave a Reply

Your email address will not be published. Required fields are marked *

error: Content is protected from copying.